OpenVSafe by OpenVAERS
Search V-safe

CGT-19119-96810

5 vaccinations 10 coded responses 58 check-ins 9 free-text entries 4 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
009 / PR
Registered
2021-01-07
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-07
    Registered in v-safe
  2. 2021-01-07
    Dose 1 — Moderna
  3. 2021-01-07
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-01-07
    Report sent to call center — day 0, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  7. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-14
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-28
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-04
    Dose 2 — Moderna
  15. 2021-02-04
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  17. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-05-06
    Survey response — 3 months, dose 2
    MedDRA: Photopsia, Vitreous floaters — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Eye floaters and photopsias on April 23, 2021
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-05-06
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2021-06-08
    Call successful
    Does not wish to fill out VAERS report
  31. 2021-08-05
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2021-10-23
    Dose 3 — Moderna
  33. 2021-10-23
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Musculoskeletal disorder — Feeling: Good · Site: Pain
    Free text: Slight limitation of my left arm upward extension
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  39. 2021-10-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  40. 2021-11-07
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  42. 2021-11-20
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-11-27
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  44. 2021-12-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-01-22
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-04-23
    Survey response — 6 months, dose 3
    MedDRA: Office visit, Vertigo positional — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Benign paroxysmal positional vertigo since approximately 1 week ago. · Healthcare visit (other): ENT
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-04-23
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  48. 2022-04-25
    Call successful
    Does not wish to fill out VAERS report
  49. 2022-07-02
    Dose 4 — Moderna
  50. 2022-07-05
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site pain — Feeling: Good
    Free text: Pain at the injection site for almost 24 hours post vaccination and that was it!
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-07-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  52. 2022-07-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  53. 2022-07-09
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  54. 2022-07-16
    Survey response — day 14, dose 4
    MedDRA: Pain in extremity, Peripheral swelling, Self-medication, Urticaria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Acute urticarial rash requiring Rx with Benadryl 50mg PO qhs, Zyxal 5mg PO qam, and after little improvement, started Methylprednisolone 4mg PO, q6hrs, going to my 3rd day on it. No fever. Did have painful hands and feet with slight swelling.
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-07-23
    Survey response — day 21, dose 4
    MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Still have the urticarial symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  56. 2022-07-30
    Survey response — day 28, dose 4
    MedDRA: Arthralgia, Mechanical urticaria, Self-medication, Urticaria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Persistent urticarial rashes & dermographism. No further joint pain, no headaches or fever. Still on Xyzal, Benadryl and Pepcid.
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-08-06
    Survey response — day 35, dose 4
    MedDRA: Mechanical urticaria, Urticaria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Persistent urticaria with dermographism since 07/11/22.
    MedDRA releases: 2024-11 · check-in free text available
  58. 2022-08-13
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  59. 2022-10-01
    Survey response — 3 months, dose 4
    MedDRA: COVID-19, Cough, Dyspepsia, Dysphonia, Headache, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school
    Free text: COVID-19 between 09/12/22-09/22/22: -hoarseness of voice, sorethroat, headache, heartburn exhacerbationwith dry cough at night -no fever or significant congestion
    MedDRA releases: 2024-11 · check-in free text available
  60. 2022-12-22
    Dose 5 — Pfizer-BioNTech
  61. 2022-12-31
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  62. 2022-12-31
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  63. 2023-01-05
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  64. 2023-01-12
    Survey response — day 21, dose 5
    MedDRA: Skin papilloma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  65. 2023-01-12
    Report sent to call center — day 21, dose 5
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  66. 2023-01-13
  67. 2023-01-19
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  68. 2023-01-19
  69. 2023-01-28
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  70. 2023-02-02
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  71. 2023-03-23
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  72. 2023-06-23
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Moderna
22021-02-04Moderna
32021-10-23Moderna No
42022-07-02Moderna No
52022-12-22Pfizer-BioNTech No

Call center

4 call center cases

3 successful · 1 unsuccessful

See the call center timeline

Free text

Release 8 — 3 months, dose 2

2021-05-06

Symptoms: Eye floaters and photopsias on April 23, 2021

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): Slight limitation of my left arm upward extension

Release 11 — 6 months, dose 3

2022-04-23

Symptoms: Benign paroxysmal positional vertigo since approximately 1 week ago.
Healthcare visit (other): ENT

Release 12 — days 1–6 daily, dose 4

2022-07-05

Systemic reaction (other): Pain at the injection site for almost 24 hours post vaccination and that was it!

Release 12 — day 14, dose 4

2022-07-16

Symptoms: Acute urticarial rash requiring Rx with Benadryl 50mg PO qhs, Zyxal 5mg PO qam, and after little improvement, started Methylprednisolone 4mg PO, q6hrs, going to my 3rd day on it. No fever. Did have painful hands and feet with slight swelling.

Release 12 — day 21, dose 4

2022-07-23

Symptoms: Still have the urticarial symptoms.

Release 12 — day 28, dose 4

2022-07-30

Symptoms: Persistent urticarial rashes & dermographism. No further joint pain, no headaches or fever. Still on Xyzal, Benadryl and Pepcid.

Release 12 — day 35, dose 4

2022-08-06

Symptoms: Persistent urticaria with dermographism since 07/11/22.

Release 12 — 3 months, dose 4

2022-10-01

Symptoms: COVID-19 between 09/12/22-09/22/22: -hoarseness of voice, sorethroat, headache, heartburn exhacerbationwith dry cough at night -no fever or significant congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDArthralgia · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDyspepsia · · ✓
SDDysphonia · · ✓
SDHeadache · · ✓
SDMechanical urticaria · · ✓
SDOropharyngeal pain · · ✓
SDPain in extremity · · ✓
SDPeripheral swelling · · ✓
SDPhotopsia ✓ ✓ ✓
SDSelf-medication · · ✓
SDSkin papilloma · · ✓
SDUrticaria · · ✓
SDVertigo positional · · ✓
SDVitreous floaters ✓ ✓ ✓
SROInjection site pain · · ✓
SROMusculoskeletal disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release